Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Market price (% of par)
-
99.44%
-
Total 13F principal
-
$491,206,888
-
Principal change
-
+$17,329,373
-
Total reported market value
-
$489,940,000
-
Number of holders
-
41
-
Value change
-
+$16,032,312
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q4 2018
As of 31 Dec 2018 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 41 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $491,206,888 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Allianz Asset Management GmbH, ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, ZAZOVE ASSOCIATES LLC, LAZARD ASSET MANAGEMENT LLC, SHENKMAN CAPITAL MANAGEMENT INC, Polar Capital LLP, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, and STATE STREET CORP.
This table shows 41 bond principal holders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.